Cargando…

Selective COX-2 inhibitor versus non-selective COX-2 inhibitor for the prevention of heterotopic ossification after total hip arthroplasty: A meta-analysis

BACKGROUND: Whether selective non-steroidal anti-inflammatory drugs (NSAIDs) has equally efficacy with non-selective NSAIDs in preventing heterotopic ossification (HO) after total hip arthroplasty (THA) was controversial. The purpose of this meta-analysis was to assess the efficacy and safety of sel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Xi-Tian, Chen, Lei, Lin, Jian-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081155/ https://www.ncbi.nlm.nih.gov/pubmed/30075549 http://dx.doi.org/10.1097/MD.0000000000011649

Ejemplares similares

Select Dietary Phytochemicals Function as Inhibitors of COX-1 but Not COX-2
por: Li, Haitao, et al.
Publicado: (2013)

Selective versus non-selective NSAIDs as prophylaxis for heterotopic ossification following hip arthroplasty: a meta-analysis
por: Migliorini, Filippo, et al.
Publicado: (2022)

Anaphylaxis to selective COX-2 inhibitors: an unexpected culprit
por: Dias de Castro, Eunice, et al.
Publicado: (2015)

The efficacy and safety of selective COX-2 inhibitors for postoperative pain management in patients after total knee/hip arthroplasty: a meta-analysis
por: Jiang, Mingyang, et al.
Publicado: (2020)

Etoricoxib is safe and effective in preventing heterotopic ossification after primary total hip arthroplasty
por: Oberberg, Stella, et al.
Publicado: (2021)

Heterotopic Ossification in Primary Total Hip Arthroplasty: which is the role of drainage?
por: Paolo Di, Benedetto, et al.
Publicado: (2019)

Heterotopic ossification after total hip arthroplasty: When is development completed?
por: Willburger, Roland E., et al.
Publicado: (2022)

Heterotopic ossification in primary total hip arthroplasty: risk factor analysis
por: Aprato, Alessandro, et al.
Publicado: (2022)

Design and Synthesis of Imidazopyrazolopyridines as Novel Selective COX-2 Inhibitors
por: Badrey, Mohamed G., et al.
Publicado: (2015)

A Short Course of Celecoxib Prevents Heterotopic Ossification Following Cementless Total Hip Arthroplasty
por: Badi, Hamid Al, et al.
Publicado: (2023)

Does drainage affect development of heterotopic ossification after total hip arthroplasty?
por: Wei, Congcong, et al.
Publicado: (2022)

Selective COX-2 inhibitor ameliorates osteoarthritis by repressing apoptosis of chondrocyte
por: Ou, Yunsheng, et al.
Publicado: (2012)

Selective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships
por: Zarghi, Afshin, et al.
Publicado: (2011)

Efficacy of Ibuprofen after Total Hip Arthroplasty to Prevent Heterotopic Ossification: Systematic Review and Meta-Analysis
por: Tariq, Muhammad Ali, et al.
Publicado: (2022)

The 2′-Trifluoromethyl Analogue of Indomethacin Is a Potent and Selective COX-2 Inhibitor
por: Blobaum, Anna L., et al.
Publicado: (2013)

Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
por: Harris, Randall E, et al.
Publicado: (2012)

Binding Energy Calculation of Patchouli Alcohol Isomer Cyclooxygenase Complexes Suggested as COX-1/COX-2 Selective Inhibitor
por: Raharjo, Sentot Joko, et al.
Publicado: (2014)

Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors
por: Mukherjee, Debabrata, et al.
Publicado: (2003)

Aspirin used for venous thromboembolism prophylaxis in total hip arthroplasty decreases heterotopic ossification
por: Vaz, Kenneth M., et al.
Publicado: (2020)

Identification of Risk Factors in the Development of Heterotopic Ossification After Primary Total Hip Arthroplasty
por: Singh, Sukhmani, et al.
Publicado: (2022)

COX-2: Where are we in 2003? - Be strong and resolute: continue to use COX-2 selective inhibitors at recommended dosages in appropriate patients
por: Hochberg, Marc C
Publicado: (2003)

Selective COX-2 inhibitors, NSAIDs and cardiovascular events – is celecoxib the safest choice?
por: Howes, Laurence Guy
Publicado: (2007)

Chondroprotective Actions of Selective COX-2 Inhibitors In Vivo: A Systematic Review
por: Timur, Ufuk Tan, et al.
Publicado: (2020)

Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing
por: El-Malah, Afaf A., et al.
Publicado: (2022)

COX-2 Inhibitors and Gastric Cancer
por: Wang, Zhen, et al.
Publicado: (2014)

Adverse Effects of COX-2 Inhibitors
por: Sharma, Jagdish N., et al.
Publicado: (2005)

Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors
por: Harris, Randall E, et al.
Publicado: (2006)

Heterotopic Ossification in Hip Arthroscopy
por: Seijas, Roberto, et al.
Publicado: (2023)

Network Meta-Analysis Comparing Relatively Selective COX-2 Inhibitors Versus Coxibs for the Prevention of NSAID-Induced Gastrointestinal Injury
por: Yang, Man, et al.
Publicado: (2015)

Heterotopic ossification in primary total hip arthroplasty using the posterolateral compared to the direct lateral approach
por: van Erp, J. H. J., et al.
Publicado: (2021)

Houttuynia cordata, a novel and selective COX-2 inhibitor with anti-inflammatory activity
por: Li, Weifeng, et al.
Publicado: (2011)

Exploring the role of COX-2 in Alzheimer's disease: Potential therapeutic implications of COX-2 inhibitors
por: Moussa, Nathalie, et al.
Publicado: (2023)

Posterior mini-incision total hip arthroplasty controls the extent of post-operative formation of heterotopic ossification
por: Edwards, D. S., et al.
Publicado: (2015)

Heterotopic Ossification: A Challenging Complication of Total Hip Arthroplasty: Risk Factors, Diagnosis, Prophylaxis, and Treatment
por: Łęgosz, Paweł, et al.
Publicado: (2019)

NSAIDs for Prophylaxis for Heterotopic Ossification After Total Hip Arthroplasty: A Bayesian Network Meta-analysis
por: Migliorini, Filippo, et al.
Publicado: (2020)

Incidence of Heterotopic Ossification in Direct Anterior Approach to Total Hip Arthroplasty with use of Aspirin as Thromboembolic Prophylaxis
por: Knapp, Paul, et al.
Publicado: (2020)

COX inhibitors and breast cancer
por: Mazhar, D, et al.
Publicado: (2006)

Heterotopic ossification after hip arthroscopy
por: Amar, Eyal, et al.
Publicado: (2015)

Heterotopic Ossification Causing Radiculopathy after Lumbar Total Disc Arthroplasty
por: Jackson, Keith L., et al.
Publicado: (2015)

Heterotopic Ossification Following Total Ankle Arthroplasty with Fourth- Generation Prostheses
por: Rushing, Calvin J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nqh6lncjdjm5gi65p8cq8famjm